Editorial: Drug Repurposing

Editorial: Drug Repurposing

Bibliographic Details
Main Authors:	Pan Pantziarka, Nicolas André
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-07-01
Series:	Frontiers in Medicine
Subjects:	drug repurposing oncology clinical cancer research drug development drug repositioning
Online Access:	https://www.frontiersin.org/article/10.3389/fmed.2019.00154/full

Similar Items

“Hard” Drug Repurposing for Precision Oncology: The Missing Link?
by: Pan Pantziarka, et al.
Published: (2018-06-01)

Repurposing Infectious Diseases Vaccines Against Cancer
by: Liese Vandeborne, et al.
Published: (2021-05-01)

An Open Access Database of Licensed Cancer Drugs
by: Pan Pantziarka, et al.
Published: (2021-03-01)

Prospects for repurposing CNS drugs for cancer treatment
by: Mohamed Abdelaleem, et al.
Published: (2019-04-01)

A Computational Model of Tumor Growth and Anakoinosis
by: Pan Pantziarka, et al.
Published: (2019-03-01)

Drug Repurposing for the Treatment of Acute Myeloid Leukemia
by: Vibeke Andresen, et al.
Published: (2017-11-01)

Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
by: Carlos Pérez-Plasencia, et al.
Published: (2021-06-01)

Repurposing Drugs to Treat Heart and Brain Illness
by: Maranda S. Cantrell, et al.
Published: (2021-06-01)

Challenges for Drug Repurposing in the COVID-19 Pandemic Era
by: Janet Sultana, et al.
Published: (2020-11-01)

Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
by: Debbie-Ann Shirley, et al.
Published: (2021-03-01)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
by: Daniele Parisi, et al.
Published: (2020-01-01)

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
by: Ciska Verbaanderd, et al.
Published: (2020-01-01)

Doxazosin, a Classic Alpha 1-Adrenoceptor Antagonist, Overcomes Osimertinib Resistance in Cancer Cells via the Upregulation of Autophagy as Drug Repurposing
by: Shuhei Suzuki, et al.
Published: (2020-08-01)

Filling the gap in CNS drug development: evaluation of the role of drug repurposing
by: A. Caban, et al.
Published: (2017-01-01)

Drug Repurposing for the Management of Depression: Where Do We Stand Currently?
by: Hosna Mohammad Sadeghi, et al.
Published: (2021-07-01)

SPIDR: small-molecule peptide-influenced drug repurposing
by: Matthew D. King, et al.
Published: (2018-04-01)

Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates
by: Laura De Lellis, et al.
Published: (2021-08-01)

Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
by: Andrés Pizzorno, et al.
Published: (2019-03-01)

Repurposing drugs for the treatment and control of helminth infections
by: Gordana Panic, et al.
Published: (2014-12-01)

Drug repurposing for the treatment of glioblastoma multiforme
by: Claudia Abbruzzese, et al.
Published: (2017-11-01)

Repurposing drugs: Lessons from rheumatology in the COVID-19 pandemic
by: Manesh Manoj, et al.
Published: (2021-01-01)

Drug Repurposing on G Protein-Coupled Receptors Using a Computational Profiling Approach
by: Alessandra de Felice, et al.
Published: (2021-05-01)

A drug repurposing study based on clinical big data for the treatment of interstitial lung disease
by: SONI, SISWANTO
Published: (2020)

A data-driven methodology towards evaluating the potential of drug repurposing hypotheses
by: Lucía Prieto Santamaría, et al.
Published: (2021-01-01)

An FDA-Drug Library Screen for Compounds with Bioactivities against Meticillin-Resistant Staphylococcus aureus (MRSA)
by: Qiu Ying Lau, et al.
Published: (2015-10-01)

Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant Acinetobacter baumannii
by: Yu-Shan Cheng, et al.
Published: (2019-01-01)

Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
by: Antonio Ancidoni, et al.
Published: (2021-05-01)

Drug Repositioning for Effective Prostate Cancer Treatment
by: Beste Turanli, et al.
Published: (2018-05-01)

Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi
by: Lucie Peyclit, et al.
Published: (2021-05-01)

The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force
by: Noel T Southall, et al.
Published: (2019-10-01)

Drug combination and repurposing for cancer therapy: the example of breast cancer
by: Ana Salomé Correia, et al.
Published: (2021-01-01)

Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer
by: Beste Turanli, et al.
Published: (2019-05-01)

Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
by: Eric Wen Su, et al.
Published: (2017-03-01)

Repurposing Anti-Cancer Drugs for COVID-19 Treatment
by: Borcherding N, et al.
Published: (2020-11-01)

Changing Trends in Computational Drug Repositioning
by: Jaswanth K. Yella, et al.
Published: (2018-06-01)

Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study
by: Daiane Dias Ferreira, et al.
Published: (2018-10-01)

VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01)

Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
by: Christina Pfab, et al.
Published: (2021-06-01)

Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway
by: Anisha S. Jain, et al.
Published: (2021-10-01)

Anthelmintics for drug repurposing: Opportunities and challenges
by: Seyed Ebrahim Alavi, et al.
Published: (2021-05-01)

Cannot write session to /tmp/vufind_sessions/sess_p9abi43nbm9qtrgmnpknm8l0sf